PDQ Insights

When measuring the success of your campaigns, the most important key performance indicators HCP marketers should keep track of are direct mail and email open rates, website visits, engagement, market qualified leads, conversions, and your return on investment.

A well-maintained HCP emailing list can be good for years, as long as you are sure to track your campaign metrics and scrub your lists for erroneous or inactive emails every six months or so.

A direct mail campaign is more impactful and leaves a more lasting impression when it is personalized, customized, creative, and informative.

The biggest challenges in HCP marketing include reaching the right physicians, gaining the trust of your audience, properly utilizing your digital platforms, and keeping your audience engaged.

On the third and final episode of our podcast series, PDQ’s Kevin Kingree and Novo Nordisk’s Wesley van den Heuvel discuss the changes HCP marketers have undergone and what the future of the industry may look like post-COVID-19.

On the second edition of our podcast series, PDQ’s Kevin Kingree and ViiV Healthcare’s Mary Andrews discuss how the pandemic has modified the duties of pharma marketers, and what this evolution means for the industry moving forward.

The inaugural episode of our podcast series features PDQ’s Kevin Kingree and Compas, Inc.’s Nicole Woodland-DeVan discussing the challenges and strategies of the pharmaceutical marketing industry in navigating the COVID-19 pandemic.

HCP marketers should include nurses in their non-personal marketing strategy because of their importance to the healthcare field, influence, and accessibility.

The efficacy of your pharmaceutical marketing strategy largely depends on its implementation, measuring and monitoring a campaign’s progress, ensuring your return on investment, and taking a multi-channeled approach that includes targeted direct mail and email.